PHIN-214

N/A

Report date: 2025/03/18 16:38:19
NME

Base Information

Drug NamePHIN-214
Drug Alias NamePHIN-214
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionVasopressin V1a receptor agonists
TargetsVasopressin V1a receptor
Therapy Area/IndicationsAscitesHypotensionLiver Cirrhosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesPharmaIN Corp
China Registration ClassN/A

Develop Information

Active CompaniesPharmaIN Corp
Inactive CompaniesN/A
Active IndicationsAscitesHypotensionLiver Cirrhosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A